Fuse Medical, Inc.

FZMD SEC CIK 319016
Follow Fuse Medical Weekly email: filings, results

Financials

Reported figures only · latest: fiscal 2022 USD · US GAAP
Revenue, last year $18.6M −8.7% vs prior year
Net income $3.1M +295.1% vs prior year
EPS, diluted $0.04 +300% vs prior year
Operating cash flow $34.8K +102% vs prior year
Revenue by fiscal year
$26.4M
$26.3M
$22.9M
$21.4M
$20.4M
$18.6M
FY17 FY18 FY19 FY20 FY21 FY22

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income12 fiscal years
  • Revenue
  • Net income
−$10M$0$10M$20M$30MFY12FY14FY16FY18FY20FY22
Show the numbers
YearRevenueNet income
FY22$18.6M$3.1M
FY21$20.4M−$1.6M
FY20$21.4M−$1.4M
FY19$22.9M−$3.3M
FY18$26.3M$4M
FY17$26.4M$699.7K
FY16$25.7M$3M
FY15$1.7M−$801.5K
FY14$941.1K−$1.4M
FY13$1.1M$435.4K
FY12-−$101.6K
FY11-−$122.3K
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
−200%−100%0%100%FY12FY14FY16FY18FY20FY22
Show the numbers
YearGross marginOperating marginNet margin
FY2261.9%−4.4%16.6%
FY2158.5%−10.8%−7.8%
FY2059.4%−4.8%−6.7%
FY1948.6%−19%−14.5%
FY1849.3%−7.4%15%
FY1744.8%3.3%2.6%
FY1656.1%12.3%11.8%
FY1560.4%−47.4%−47.8%
FY1448.4%−141.8%−149.3%
FY1380.8%41.2%41.1%
FY12---
FY11---
Free cash flowOperating cash flow minus capital expenditure
−$2M−$1M$0$1M$2M$3MFY12FY14FY16FY18FY20FY22
Show the numbers
YearFree cash flow
FY22-
FY21-
FY20$215.9K
FY19−$20.1K
FY18$2.4M
FY17$1.6M
FY16-
FY15−$383.4K
FY14−$1.2M
FY13$317.9K
FY12-
FY11-
Net margin vs the sectorMedian of Consumer companies filing with the SEC
  • Fuse Medical
  • Consumer median
−150%−100%−50%0%50%FY12FY14FY16FY18FY20FY22
Show the numbers
YearFuse MedicalConsumer median
FY2216.6%2.5%
FY21−7.8%2.5%
FY20−6.7%1.8%
FY19−14.5%2.6%
FY1815%3.8%
FY172.6%3.8%
FY1611.8%4.3%
FY15−47.8%3.8%
FY14−149.3%3.6%
FY1341.1%3.9%
FY12-4.1%
FY11-2.9%